Lineage Cell Therapeutics News

Lineage Cell Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Culley Brian M

May 28 08:16

Lineage Cell Therapeutics | EFFECT: Others

May 15 05:40

Lineage Cell Therapeutics | 8-K: Current report

May 14 15:42

Lineage Cell Therapeutics | 424B5: Prospectus

May 14 15:42

Lineage Cell Therapeutics | 8-K: LINEAGE CELL THERAPEUTICS REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

May 9 16:09

Lineage Cell Therapeutics | 10-Q: Quarterly report

May 9 16:03

Lineage Cell Therapeutics | ARS: Annual Report to Security Holders

Apr 29 15:55

Lineage Cell Therapeutics | DEFA14A: Others

Apr 29 15:46

Lineage Cell Therapeutics | DEF 14A: Definitive information statements

Apr 29 15:37

Lineage Cell Therapeutics | 424B5: Prospectus

Mar 22 15:36

Lineage Cell Therapeutics | 8-K: Current report

Mar 22 15:18

Lineage Cell Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Howe Jill Ann

Mar 8 15:07

Lineage Cell Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Samuel George A. III

Mar 8 15:07

Lineage Cell Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Culley Brian M

Mar 8 15:07

Lineage Cell Therapeutics | 10-K: Annual report

Mar 7 21:16

Lineage Cell Therapeutics | S-3: Registration statement for specified transactions by certain issuers

Mar 7 16:21

Lineage Cell Therapeutics | 8-K: LINEAGE CELL THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

Mar 7 15:16

Lineage Cell Therapeutics | 8-K: Current report

Feb 15 16:34

Lineage Cell Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Samuel George A. III

Feb 12 20:31

Lineage Cell Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Culley Brian M

Feb 12 20:31